170 related articles for article (PubMed ID: 1835715)
1. Estrogen inhibition of MPA-induced mouse mammary tumor transplants.
Kordon E; Lanari C; Molinolo AA; Elizalde PV; Charreau EH; Dosne Pasqualini C
Int J Cancer; 1991 Dec; 49(6):900-5. PubMed ID: 1835715
[TBL] [Abstract][Full Text] [Related]
2. Reversal of estrogen-resistance in murine mammary adenocarcinomas.
Montecchia MF; Molinolo A; Lanari C
Breast Cancer Res Treat; 1999 Mar; 54(2):93-9. PubMed ID: 10424399
[TBL] [Abstract][Full Text] [Related]
3. Hormone dependence of a mouse mammary tumor line induced in vivo by medroxyprogesterone acetate.
Kordon E; Lanari C; Meiss R; Elizalde P; Charreau E; Dosne Pasqualini C
Breast Cancer Res Treat; 1990 Nov; 17(1):33-43. PubMed ID: 2151368
[TBL] [Abstract][Full Text] [Related]
4. Mammary adenocarcinomas induced by medroxyprogesterone acetate: hormone dependence and EGF receptors of BALB/c in vivo sublines.
Lanari C; Kordon E; Molinolo A; Pasqualini CD; Charreau EH
Int J Cancer; 1989 May; 43(5):845-50. PubMed ID: 2523869
[TBL] [Abstract][Full Text] [Related]
5. Progesterone receptor involvement in independent tumor growth in MPA-induced murine mammary adenocarcinomas.
Montecchia MF; Lamb C; Molinolo AA; Luthy IA; Pazos P; Charreau E; Vanzulli S; Lanari C
J Steroid Biochem Mol Biol; 1999 Jan; 68(1-2):11-21. PubMed ID: 10215033
[TBL] [Abstract][Full Text] [Related]
6. Mouse mammary tumors induced by medroxyprogesterone acetate: immunohistochemistry and hormonal receptors.
Molinolo AA; Lanari C; Charreau EH; Sanjuan N; Pasqualini CD
J Natl Cancer Inst; 1987 Dec; 79(6):1341-50. PubMed ID: 2826865
[TBL] [Abstract][Full Text] [Related]
7. [Progestin-induced mammary adenocarcinomas in BALB/c mice. Progression from hormone-dependent to autonomous tumors].
Lanari C; Montecchia MF; Pazos P; Simian M; Vanzulli S; Lamb C; Molinolo AA
Medicina (B Aires); 1997; 57 Suppl 2():55-69. PubMed ID: 9567344
[TBL] [Abstract][Full Text] [Related]
8. Effect of medroxyprogesterone acetate (MPA) and serum factors on cell proliferation in primary cultures of an MPA-induced mammary adenocarcinoma.
Dran G; Luthy IA; Molinolo AA; Montecchia F; Charreau EH; Pasqualini CD; Lanari C
Breast Cancer Res Treat; 1995 Aug; 35(2):173-86. PubMed ID: 7647339
[TBL] [Abstract][Full Text] [Related]
9. Mammary carcinogenesis induced by N-methyl-N-nitrosourea (MNU) and medroxyprogesterone acetate (MPA) in BALB/c mice.
Pazos P; Lanari C; Meiss R; Charreau EH; Pasqualini CD
Breast Cancer Res Treat; 1992 Jan; 20(2):133-8. PubMed ID: 1554889
[TBL] [Abstract][Full Text] [Related]
10. Progesterone induction of mammary carcinomas in BALB/c female mice. Correlation between progestin dependence and morphology.
Kordon EC; Molinolo AA; Pasqualini CD; Charreau EH; Pazos P; Dran G; Lanari C
Breast Cancer Res Treat; 1993 Oct; 28(1):29-39. PubMed ID: 8123867
[TBL] [Abstract][Full Text] [Related]
11. Embryonal mass and hormone-associated effects of pregnancy inducing a differential growth of four murine tumors.
Bustuoabad OD; di Gianni PD; Franco M; Kordon EC; Vanzulli SI; Meiss RP; Grion LC; Díaz GS; Nosetto SH; Hockl P; Lombardi MG; Pasqualini CD; Ruggiero RA
Oncol Res; 2002; 13(3):147-60. PubMed ID: 12549624
[TBL] [Abstract][Full Text] [Related]
12. Five novel hormone-responsive cell lines derived from murine mammary ductal carcinomas: in vivo and in vitro effects of estrogens and progestins.
Lanari C; Lüthy I; Lamb CA; Fabris V; Pagano E; Helguero LA; Sanjuan N; Merani S; Molinolo AA
Cancer Res; 2001 Jan; 61(1):293-302. PubMed ID: 11196177
[TBL] [Abstract][Full Text] [Related]
13. Establishment of two hormone-responsive mouse mammary carcinoma cell lines derived from a metastatic mammary tumor.
Efeyan A; Fabris V; Merani S; Lanari C; Molinolo AA
Breast Cancer Res Treat; 2004 Feb; 83(3):233-44. PubMed ID: 14758093
[TBL] [Abstract][Full Text] [Related]
14. Sequential hormone therapy with medroxyprogesterone acetate for 7, 12-dimethylbenz [alpha] anthracene-induced rat mammary tumors.
Iino Y; Ishikawa H; Izuo M; Takikawa H
Jpn J Clin Oncol; 1989 Mar; 19(1):45-50. PubMed ID: 2522157
[TBL] [Abstract][Full Text] [Related]
15. Correlation of TGF-beta 1 expression with medroxyprogesterone acetate responsiveness in mouse mammary adenocarcinomas.
Elizalde PV; Guerra FK; Gravano M; Lanari C; Lippman ME; Charreau EH; Lupu R
Cancer Invest; 1995; 13(2):173-80. PubMed ID: 7874571
[TBL] [Abstract][Full Text] [Related]
16. Association of estrogen receptor-alpha and progesterone receptor A expression with hormonal mammary carcinogenesis: role of the host microenvironment.
Montero Girard G; Vanzulli SI; Cerliani JP; Bottino MC; Bolado J; Vela J; Becu-Villalobos D; Benavides F; Gutkind S; Patel V; Molinolo A; Lanari C
Breast Cancer Res; 2007; 9(2):R22. PubMed ID: 17341305
[TBL] [Abstract][Full Text] [Related]
17. Induction of mammary adenocarcinomas by medroxyprogesterone acetate in BALB/c female mice.
Lanari C; Molinolo AA; Pasqualini CD
Cancer Lett; 1986 Nov; 33(2):215-23. PubMed ID: 2947675
[TBL] [Abstract][Full Text] [Related]
18. Potentiation of medroxyprogesterone acetate antineoplastic activity by histidine in rat mammary tumours.
Di Carlo F; Conti G; Giubertoni M; Muccioli G; Racca S
Cancer Chemother Pharmacol; 1991; 27(4):271-7. PubMed ID: 1825621
[TBL] [Abstract][Full Text] [Related]
19. Additive inhibitory effects of bromocryptine (CB-154) and medroxyprogesterone acetate (MPA) on dimethylbenz[a]anthracene (DMBA)-induced mammary tumors in the rat.
Dauvois S; Spinola PG; Labrie F
Eur J Cancer Clin Oncol; 1989 May; 25(5):891-7. PubMed ID: 2525471
[TBL] [Abstract][Full Text] [Related]
20. Regulation of cell growth of a progestin-dependent murine mammary carcinoma in vitro: progesterone receptor involvement in serum or growth factor-induced cell proliferation.
Lamb C; Simian M; Molinolo A; Pazos P; Lanari C
J Steroid Biochem Mol Biol; 1999; 70(4-6):133-42. PubMed ID: 10622401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
